ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Silencing XIST mitigated lipopolysaccharide (LPS)-induced inflammatory injury in human lung fibroblast WI-38 cells through modulating miR-30b-5p/CCL16 axis and TLR4/NF-κB signaling pathway

Xu, Jiahui; Li, Honggui; Lv, Ying; Zhang, Chang; Chen, Yiting; Yu, Dezhao*广州中医药大学; 南方医科大学; 1; 5
Open Life Sciences2021DOI: 10.1515/biol-2021-0005
11被引3阅读
引用收藏
分享

摘要

Background - Emerging evidence shows that long non-coding RNA (lncRNA) has been a novel insight in various diseases, including pneumonia. Even though lncRNA X-inactive-specific transcript (XIST) is well studied, its role in pneumonia remains to be largely unrevealed. @@@ Methods - Expression of XIST, miR-NA-30b-5p (miR-30b-5p), and CC chemokine ligand 16 (CCL16) was detected using reverse transcriptase quantitative polymerase chain reaction and western blotting; their interaction was confirmed by dual-luciferase reporter assay. Apoptosis, inflammation, and toll-like receptor 4 (TLR4)/NF-kappa B signaling pathway were measured using methyl thiazolyl tetrazolium assay, flow cytometry, western blotting, and enzyme-linked immunosorbent assay. @@@ Results - Lipopolysaccharide (LPS) stimulation decreased cell viability and B cell lymphoma (Bcl)-2 expression, and increased cell apoptosis rate and expression of Bcl-2-associated X protein (Bax), cleaved-caspase-3, interleukin (IL)-6, IL-1 beta, and tumor necrosis factor alpha (TNF-alpha) in WI-38 cells. Expression of XIST and CCL16 was upregulated in the serum of patients with pneumonia and LPS-induced WI-38 cells, respectively; silencing XIST and CCL16 could suppress LPS-induced apoptosis and inflammation in WI-38 cells, and this protection was abolished by miR-30b-5p downregulation. Moreover, XIST and CCL16 could physically bind to miR-30b-5p, and XIST regulated CCL16 expression via sponging miR-30b-5p. TLR4 and phosphorylated P65 (p-P65) and p-I kappa B-alpha were highly induced by LPS treatment, and this upregulation was diminished by blocking XIST, accompanied with CCL16 downregulation and miR-30b-5p upregulation. @@@ Conclusions - Silencing XIST could alleviate LPS-induced inflammatory injury in human lung fibroblast WI-38 cells through modulating miR-30b-5p/CCL16 axis and inhibiting TLR4/NF-kappa B signaling pathway.

学科与关键词

关键词
XISTmiR-30b-5pLPS-induced WI-38 cellsCCL16pneumoniaTLR4/NF-kappa B
相关
加载中…
  • STAT3-activated lncRNA XIST accelerates the inflammatory response and apoptosis of LPS-induced acute lung injury
    Li, Jun; Xue, Lei; Wu, Yunfei; Yang, Qiang; Liu, Degang; Yu, Changhui*; Peng, Jiangzhou*Journal of Cellular and Molecular Medicine, 2021, 25(14): 6550-6557.被引 12
  • LncRNA small nucleolar RNA host gene 16 (SNHG16) silencing protects lipopolysaccharide (LPS)-induced cell injury in human lung fibroblasts WI-38 through acting as miR-141-3p sponge
    Xia, Lei; Zhu, Guoqing; Huang, Haiyun; He, Yishui; Liu, Xingguang*Bioscience, Biotechnology and Biochemistry, 2021, 85(5): 1077-1087.被引 7
  • LncRNA XIST facilitates hypertrophy of ligamentum flavum by activating VEGFA-mediated autophagy through sponging miR-302b-3p
    Cao, Yanlin; Li, Jianjun; Qiu, Sujun; Ni, Songjia; Duan, Yang*Biology Direct, 2023, 18(1): 25.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Open Life Sciences
发表日期
2021
卷期
第 16 卷, 第 1 期
页码
108-127
DOI
10.1515/biol-2021-0005
语言
ENGLISH
期刊收录
NSL
期刊等级
4区
成果收录
SCIE
资助标注
Natural Science Foundation of Guangdong Province [2014A030313646023]

作者

  • X

    Xu, Jiahui (第一作者)

    5 · guangzhou univ tradit chinese med

  • L

    Li, Honggui

    1 · guangzhou univ tradit chinese med

查看全部 6 位作者收起作者
  • L

    Lv, Ying

    5 · guangzhou univ tradit chinese med

  • Z

    Zhang, Chang

  • C

    Chen, Yiting

    southern med univ

  • Y

    Yu, Dezhao (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417